Skip to content

Classification of Invasiveness and Prediction of Ki-67 Expression Level in Pulmonary Ground-Glass Nodules Based on CT Images Using Artificial Intelligence

Aug 2026 · Journal of Mechanics in Medicine and Biology · 0 citations

Abstract

This work aimed to accurately determine the invasiveness level of pulmonary ground-glass nodules (GGNs) preoperatively and to adjust personalized treatment plans accordingly. This paper presents a multi-task artificial intelligence framework to simultaneously perform three-class invasiveness classification of GGNs and prediction of Ki-67 expression levels, and enhances the clinical transparency and potential utility of the model through multi-dimensional explainability analysis. A total of 900 patients with histologically confirmed lung adenocarcinoma presenting as GGNs were retrospectively enrolled from three hospitals: 60% were assigned to the training set, 15% to the internal validation set, 15% to the external validation set, and 10% to the external test set. A multi-task multi-instance learning framework integrating 3D Res2Net deep features, radiomic features, and clinical variables (MT-MIL-RF) was proposed. A gated attention mechanism and a cross-task attention module were introduced to learn the potential biological association between invasiveness classification and Ki-67 prediction. An independent interpretability structure has been constructed, and both Shapley Additive exPlanations (SHAP) variable attribution and Gradient-weighted Class Activation Mapping (Grad-CAM) spatial localisation have been employed. The principal contribution of this work is a validated AI framework that, for the first time, provides a simultaneous, non-invasive assessment of both the invasiveness and proliferative activity (Ki-67) of GGNs. By demonstrating that a multi-task learning strategy with cross-task attention significantly outperforms conventional single-task models, we offer a clinically promising and transparent tool to improve personalized surgical planning and risk stratification for lung adenocarcinoma.

View source

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.